PT923568E - Novas benzofuran-4-carboxamidas - Google Patents

Novas benzofuran-4-carboxamidas

Info

Publication number
PT923568E
PT923568E PT97942858T PT97942858T PT923568E PT 923568 E PT923568 E PT 923568E PT 97942858 T PT97942858 T PT 97942858T PT 97942858 T PT97942858 T PT 97942858T PT 923568 E PT923568 E PT 923568E
Authority
PT
Portugal
Prior art keywords
carboxamides
new benzofuran
benzofuran
new
substituted
Prior art date
Application number
PT97942858T
Other languages
English (en)
Portuguese (pt)
Inventor
Hans-Peter Kley
Christian Schudt
Rolf Beume
Dietrich Hafner
Ulrich Thibaut
Wolf-Rudiger Ulrich
Dieter Flockerzi
Beate Schmidt
Armin Hatzelmann
Hermann Amschler
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PT923568E publication Critical patent/PT923568E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Table Devices Or Equipment (AREA)
PT97942858T 1996-08-19 1997-08-13 Novas benzofuran-4-carboxamidas PT923568E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19633052 1996-08-19

Publications (1)

Publication Number Publication Date
PT923568E true PT923568E (pt) 2003-04-30

Family

ID=7802799

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97942858T PT923568E (pt) 1996-08-19 1997-08-13 Novas benzofuran-4-carboxamidas

Country Status (11)

Country Link
US (1) US6211203B1 (enExample)
EP (1) EP0923568B9 (enExample)
JP (1) JP4309475B2 (enExample)
AT (1) ATE229516T1 (enExample)
AU (1) AU4454597A (enExample)
CY (1) CY2458B1 (enExample)
DE (1) DE69717827T2 (enExample)
DK (1) DK0923568T5 (enExample)
ES (1) ES2188983T4 (enExample)
PT (1) PT923568E (enExample)
WO (1) WO1998007715A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100042A3 (en) * 1996-05-20 2003-01-28 Darwin Discovery Ltd Cambridge Benzofuran carboxamides medicaments containing the same and their therapeutic use
AU2529799A (en) * 1998-02-09 1999-08-23 Darwin Discovery Limited Benzofuran-4-carboxamides and their therapeutic use
TW555759B (en) * 1998-06-08 2003-10-01 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
EP1086096B1 (de) * 1998-06-10 2003-07-23 ALTANA Pharma AG Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4
CA2345459A1 (en) * 1998-11-12 2000-05-18 Regine Bohacek Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
DE19924340A1 (de) 1999-05-27 2000-11-30 Basf Ag Verfahren zur selektiven Hydrierung von ethylenisch ungesättigten Doppelbindungen in Polymeren
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
GB0003257D0 (en) 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7842713B2 (en) * 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
KR101258331B1 (ko) 2008-09-11 2013-04-26 화이자 인코포레이티드 헤테로아릴 아미드 유도체 및 글루코키나제 활성화제로서의 그의 용도
AR074760A1 (es) * 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
UA99882C2 (uk) 2009-03-11 2012-10-10 Пфайзер Інк. Похідні бензофуранілу, фармацевтична композиція та спосіб лікування захворювань (варіанти)
RU2446143C2 (ru) * 2010-05-19 2012-03-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" (ЯГТУ) Способ получения эфиров замещенных 5,6-дицианобензофуран-2-карбоновых кислот
CA2801182A1 (en) * 2010-06-16 2011-12-22 Metabolex, Inc. Gpr120 receptor agonists and uses thereof
US8299117B2 (en) 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
JP7295105B6 (ja) * 2017-11-10 2023-07-24 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 ベンゾフラン誘導体の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0706513T1 (en) * 1993-07-02 2002-10-31 Altana Pharma Ag Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
MX9700557A (es) * 1994-07-22 1997-12-31 Byk Gulden Lomberg Chem Fab Dihidrobenzofuranos.
DE69636086T2 (de) * 1995-05-19 2006-11-30 Kyowa Hakko Kogyo Co., Ltd. Sauerstoff enthaltende heterocyclische verbindungen
CN1100773C (zh) * 1995-12-05 2003-02-05 达尔文发现有限公司 苯并呋喃羧酸胺和磺酰胺
HUP0100042A3 (en) * 1996-05-20 2003-01-28 Darwin Discovery Ltd Cambridge Benzofuran carboxamides medicaments containing the same and their therapeutic use

Also Published As

Publication number Publication date
ES2188983T4 (es) 2004-06-01
WO1998007715A9 (en) 1999-04-29
ATE229516T1 (de) 2002-12-15
WO1998007715A1 (en) 1998-02-26
JP2000516932A (ja) 2000-12-19
EP0923568A1 (en) 1999-06-23
CY2458B1 (en) 2005-06-03
DE69717827T2 (de) 2003-09-04
US6211203B1 (en) 2001-04-03
EP0923568B1 (en) 2002-12-11
DE69717827D1 (de) 2003-01-23
ES2188983T3 (es) 2003-07-01
AU4454597A (en) 1998-03-06
JP4309475B2 (ja) 2009-08-05
DK0923568T5 (da) 2003-11-03
EP0923568B9 (en) 2003-08-13
DK0923568T3 (da) 2003-04-07

Similar Documents

Publication Publication Date Title
PT923568E (pt) Novas benzofuran-4-carboxamidas
EA199700061A1 (ru) Способ получения силденафила
PT841929E (pt) Quinolonas e sua utilizacao terapeutica
ATE211139T1 (de) Tetrahydroimidazopyridoindoldione als cgmp spezifische pde hemmer
ATE260103T1 (de) Ortho-anthranilamide derivate als antikoagulantien
MX9700557A (es) Dihidrobenzofuranos.
FI974180A0 (fi) Spirosyklisiä ja bisyklisiä diatsinyyli- ja karbatsinyylioksatsolidinoneja
MX9205678A (es) Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.
DK0923554T3 (da) N-Benzylpiperidin- og tetrahydropyridinderivater
DE69719358D1 (de) Substituierte dihydrobenzofurane als pde-hemmstoffe
EP0932606A4 (en) Inhibitors of prenyl transferases
DE59100597D1 (de) Verwendung von N-Alkyl-lactamen als Kristallisationsinhibitoren.
DK0944616T3 (da) Bicykliske arylcarboxamider og deres terapeutiske anvendelse
ES2071325T3 (es) Derivados de 4-alquilimidazol.
WO2003018549A3 (en) Bicyclic compounds as inhibitors of chemokine binding to us28
FI955118A0 (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
EA200200381A1 (ru) Тетрагидротиопиранфталазиноновые производные в качестве ингибиторов pde4
ATE219481T1 (de) 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivative
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
DE69025817D1 (de) 3-Keto-HMG-CoA Reduktase-Inhibitoren
SU1786802A1 (ru) 2,4-ДИМЕТИЛ-9-ОКСИПИРИДО[1,2-a]ПИРИМИДИНИЙХЛОРИД, ОБЛАДАЮЩИЙ АНТИДЕПРЕССИВНОЙ АКТИВНОСТЬЮ
SU1690242A1 (ru) Антифидант
UY24326A1 (es) Nuevas piperidinas.
NO994997L (no) Alkaloidhalidsalter av swainsonin og fremgangsmåter ved anvendelse